- Home
- ALEC vs ERH Comparison
ALEC vs ERH Comparison
Compare ALEC & ERH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALEC
- ERH
- Stock Information
- Founded
- ALEC 2013
- ERH 2004
- Country
- ALEC United States
- ERH United States
- Employees
- ALEC N/A
- ERH N/A
- Industry
- ALEC Biotechnology: Biological Products (No Diagnostic Substances)
- ERH Finance/Investors Services
- Sector
- ALEC Health Care
- ERH Finance
- Exchange
- ALEC Nasdaq
- ERH Nasdaq
- Market Cap
- ALEC 124.0M
- ERH 106.1M
- IPO Year
- ALEC 2019
- ERH N/A
- Fundamental
- Price
- ALEC $2.95
- ERH $12.06
- Analyst Decision
- ALEC Buy
- ERH
- Analyst Count
- ALEC 8
- ERH 0
- Target Price
- ALEC $4.50
- ERH N/A
- AVG Volume (30 Days)
- ALEC 1.2M
- ERH 23.2K
- Earning Date
- ALEC 11-05-2025
- ERH 01-01-0001
- Dividend Yield
- ALEC N/A
- ERH 8.85%
- EPS Growth
- ALEC N/A
- ERH N/A
- EPS
- ALEC N/A
- ERH N/A
- Revenue
- ALEC $81,130,000.00
- ERH N/A
- Revenue This Year
- ALEC N/A
- ERH N/A
- Revenue Next Year
- ALEC $196.86
- ERH N/A
- P/E Ratio
- ALEC N/A
- ERH N/A
- Revenue Growth
- ALEC 46.77
- ERH N/A
- 52 Week Low
- ALEC $0.87
- ERH $7.97
- 52 Week High
- ALEC $6.37
- ERH $10.91
- Technical
- Relative Strength Index (RSI)
- ALEC 62.76
- ERH 54.12
- Support Level
- ALEC $2.71
- ERH $12.01
- Resistance Level
- ALEC $3.00
- ERH $12.13
- Average True Range (ATR)
- ALEC 0.22
- ERH 0.11
- MACD
- ALEC -0.01
- ERH -0.00
- Stochastic Oscillator
- ALEC 74.29
- ERH 71.43
About ALEC Alector Inc.
Alector Inc is a clinical-stage biopharmaceutical company. It is engaged in developing a novel therapeutic approach for the treatment of neurodegeneration. The firm is involved in developing therapies that are designed to simultaneously counteract pathologies by restoring healthy immune function to the brain. Its pipeline products include AL001, AL002, AL003, and AL101.
About ERH Allspring Utilities and High Income Fund
Allspring Utilities and High Income Fund is a diversified closed-end management investment company. Its investment objective is to seek a high level of current income and moderate capital growth, with an emphasis on providing tax-advantaged dividend income. The company allocates a majority of its total assets to a sleeve that places a focus on common, preferred, and convertible preferred stocks of utility companies and the rest of its total assets to a sleeve of U.S. dollar denominated below investment grade (high yield) debt.